Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 16/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | ADRA2A | P08913 | 6/20 | 0.50 |
| ▸ | HRH1 | P35367 | 5/20 | 0.50 |
| ▸ | HTR2B | P41595 | 4/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6877214 | 1.00 | MCHR1 (0.53) | MCHR1HPGDADRA2AHRH1HTR2B | |
| SCHEMBL6876416 | 0.88 | HPGD (0.61) | MCHR1HPGDADRA2AHRH1HTR2B | |
| SCHEMBL6876408 | 0.88 | HPGD (0.61) | MCHR1HPGDADRA2AHRH1HTR2B | |
| SCHEMBL6463743 | 0.88 | MCHR1 (0.54) | MCHR1ADRA2AHRH1HTR2BADRA1A | |
| SCHEMBL6463737 | 0.88 | MCHR1 (0.54) | MCHR1ADRA2AHRH1HTR2BADRA1A | |
| SCHEMBL6460390 | 0.86 | MCHR1 (0.67) | MCHR1ADRA2AHRH1HTR2BADRA1A | |
| SCHEMBL6457537 | 0.86 | MCHR1 (0.67) | MCHR1ADRA2AHRH1HTR2BADRA1A | |
| SCHEMBL6460398 | 0.86 | MCHR1 (0.67) | MCHR1ADRA2AHRH1HTR2BADRA1A | |
| SCHEMBL6457552 | 0.86 | MCHR1 (0.67) | MCHR1ADRA2AHRH1HTR2BADRA1A | |
| SCHEMBL6879002 | 0.86 | MCHR1 (0.58) | MCHR1ADRA2AHRH1HTR2BADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1464335-A2 | Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist | Taisho Pharmaceutical Co. Ltd. (JP) | 2004-10-06 | — | — | EP | disclosed |